Michael Mullette joined Lykos Therapeutics as chief operating officer in March of 2022. He is an experienced drug development and commercialization professional with decades of experience growing businesses. Mike most recently served as vice president of North America commercial operations for Moderna, where he oversaw commercialization of the company’s COVID-19 vaccine during the height of the pandemic. Before Moderna he spent almost 20 years with Sanofi working in commercial, business development, operations, strategy, planning, marketing and sales in roles of increasing levels of responsibility. Mike earned his Bachelor of Business Administration from Villanova University and an M.B.A. from Lehigh University.